Managing clinical trials
<p>Abstract</p> <p>Managing clinical trials, of whatever size and complexity, requires efficient trial management. Trials fail because tried and tested systems handed down through apprenticeships have not been documented, evaluated or published to guide new trialists starting out i...
Main Authors: | Kenyon Sara, Farrell Barbara, Shakur Haleema |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/78 |
Similar Items
-
Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
by: Shakur Haleema, et al.
Published: (2009-12-01) -
Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results
by: Raoul Mansukhani, et al.
Published: (2020-07-01) -
A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
by: Abda Mahmood, et al.
Published: (2017-07-01) -
A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan [version 3; peer review: 2 approved, 2 approved with reservations]
by: Abda Mahmood, et al.
Published: (2019-11-01) -
A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan [version 2; peer review: 2 approved, 1 approved with reservations]
by: Abda Mahmood, et al.
Published: (2019-01-01)